1. INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. WHO SHOULD READ THIS REPORT?
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1 SECONDARY RESEARCH
1.4.2 DATA ANALYSIS FRAMEWORK
1.4.3 MARKET SIZE ESTIMATION
1.4.4 FORECASTING
1.4.5 PRIMARY RESEARCH AND DATA VALIDATION
2. BIOPHARMACEUTICAL MARKET – EXECUTIVE SUMMARY
2.1. MARKET SNAPSHOT, 2020 - 2030, MILLION USD
3. MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. MARKET DYNAMICS
3.2.1 DRIVERS
3.2.1.1 HIGH PREVALENCE OF CHRONIC DISEASES ACROSS THE GLOBE
3.2.1.2 STRONG ADOPTION OF BIOPHARMACEUTICALS IN DEVELOPING ECONOMIES
3.2.2 RESTRAINTS
3.2.2.1 HIGH COST ASSOCIATED WITH DRUG DEVELOPMENT AND THE THREAT OF FAILURE
3.2.3 OPPORTUNITIES
3.2.3.1 INCREASING R&D INVESTMENTS
4. COVID-19 ANALYSIS
4.1. IMPACT OF COVID-19 ON BIOPHARMACEUTICALS MARKET
5. MARKET SHARE ANALYSIS
5.1. MARKET SHARE ANALYSIS OF TOP 10 BIOPHARMACEUTICAL PROVIDERS, 2020
6. GLOBAL BIOPHARMACEUTICALS MARKET, BY PRODUCT
6.1. OVERVIEW
6.2. MONOCLONAL ANTIBODY
6.2.1 MONOCLONAL ANTIBODY MARKET, BY REGION
6.2.1.1 NORTH AMERICA MONOCLONAL ANTIBODY MARKET, BY COUNTRY
6.2.1.2 EUROPE MONOCLONAL ANTIBODY MARKET, BY COUNTRY
6.2.1.3 ASIA-PACIFIC MONOCLONAL ANTIBODY MARKET, BY COUNTRY
6.2.1.4 REST OF THE WORLD MONOCLONAL ANTIBODY MARKET, BY COUNTRY
6.3. INTERFERON
6.3.1 INTERFERON MARKET, BY REGION
6.3.1.1 NORTH AMERICA INTERFERON MARKET, BY COUNTRY
6.3.1.2 EUROPE INTERFERON MARKET, BY COUNTRY
6.3.1.3 ASIA-PACIFIC INTERFERON MARKET, BY COUNTRY
6.3.1.4 REST OF THE WORLD INTERFERON MARKET, BY COUNTRY
6.4. INSULIN
6.4.1 INSULIN MARKET, BY REGION
6.4.1.1 NORTH AMERICA INSULIN MARKET, BY COUNTRY
6.4.1.2 EUROPE INSULIN MARKET, BY COUNTRY
6.4.1.3 ASIA-PACIFIC INSULIN MARKET, BY COUNTRY
6.4.1.4 REST OF THE WORLD INSULIN MARKET, BY COUNTRY
6.5. GROWTH AND COAGULATION FACTOR
6.5.1 GROWTH AND COAGULATION FACTOR MARKET, BY REGION
6.5.1.1 NORTH AMERICA GROWTH AND COAGULATION FACTOR MARKET, BY COUNTRY
6.5.1.2 EUROPE GROWTH AND COAGULATION FACTOR MARKET, BY COUNTRY
6.5.1.3 ASIA-PACIFIC GROWTH AND COAGULATION FACTOR MARKET, BY COUNTRY
6.5.1.4 REST OF THE WORLD GROWTH AND COAGULATION FACTOR MARKET, BY COUNTRY
6.6. ERYTHROPOIETIN
6.6.1 ERYTHROPOIETIN MARKET, BY REGION
6.6.1.1 NORTH AMERICA ERYTHROPOIETIN MARKET, BY COUNTRY
6.6.1.2 EUROPE ERYTHROPOIETIN MARKET, BY COUNTRY
6.6.1.3 ASIA-PACIFIC ERYTHROPOIETIN MARKET, BY COUNTRY
6.6.1.4 REST OF THE WORLD ERYTHROPOIETIN MARKET, BY COUNTRY
6.7. VACCINE
6.7.1 VACCINE MARKET, BY REGION
6.7.1.1 NORTH AMERICA VACCINE MARKET, BY COUNTRY
6.7.1.2 EUROPE VACCINE MARKET, BY COUNTRY
6.7.1.3 ASIA-PACIFIC VACCINE MARKET, BY COUNTRY
6.7.1.4 REST OF THE WORLD VACCINE MARKET, BY COUNTRY
6.8. HORMONE
6.8.1 HORMONE MARKET, BY REGION
6.8.1.1 NORTH AMERICA HORMONE MARKET, BY COUNTRY
6.8.1.2 EUROPE HORMONE MARKET, BY COUNTRY
6.8.1.3 ASIA-PACIFIC HORMONE MARKET, BY COUNTRY
6.8.1.4 REST OF THE WORLD HORMONE MARKET, BY COUNTRY
6.9. OTHERS
6.9.1 OTHERS MARKET, BY REGION
6.9.1.1 NORTH AMERICA OTHERS MARKET, BY COUNTRY
6.9.1.2 EUROPE OTHERS MARKET, BY COUNTRY
6.9.1.3 ASIA-PACIFIC OTHERS MARKET, BY COUNTRY
6.9.1.4 REST OF THE WORLD OTHERS MARKET, BY COUNTRY
7. GLOBAL BIOPHARMACEUTICALS MARKET, BY APPLICATION
7.1. OVERVIEW
7.2. ONCOLOGY
7.2.1 ONCOLOGY MARKET, BY REGION
7.2.1.1 NORTH AMERICA ONCOLOGY MARKET, BY COUNTRY
7.2.1.2 EUROPE ONCOLOGY MARKET, BY COUNTRY
7.2.1.3 ASIA-PACIFIC ONCOLOGY MARKET, BY COUNTRY
7.2.1.4 REST OF THE WORLD ONCOLOGY MARKET, BY COUNTRY
7.3. BLOOD DISORDER
7.3.1 BLOOD DISORDER MARKET, BY REGION
7.3.1.1 NORTH AMERICA BLOOD DISORDER MARKET, BY COUNTRY
7.3.1.2 EUROPE BLOOD DISORDER MARKET, BY COUNTRY
7.3.1.3 ASIA-PACIFIC BLOOD DISORDER MARKET, BY COUNTRY
7.3.1.4 REST OF THE WORLD BLOOD DISORDER MARKET, BY COUNTRY
7.4. METABOLIC DISEASE
7.4.1 METABOLIC DISEASE MARKET, BY REGION
7.4.1.1 NORTH AMERICA METABOLIC DISEASE MARKET, BY COUNTRY
7.4.1.2 EUROPE METABOLIC DISEASE MARKET, BY COUNTRY
7.4.1.3 ASIA-PACIFIC METABOLIC DISEASE MARKET, BY COUNTRY
7.4.1.4 REST OF THE WORLD METABOLIC DISEASE MARKET, BY COUNTRY
7.5. INFECTIOUS DISEASE
7.5.1 INFECTIOUS DISEASE MARKET, BY REGION
7.5.1.1 NORTH AMERICA INFECTIOUS DISEASE MARKET, BY COUNTRY
7.5.1.2 EUROPE INFECTIOUS DISEASE MARKET, BY COUNTRY
7.5.1.3 ASIA-PACIFIC INFECTIOUS DISEASE MARKET, BY COUNTRY
7.5.1.4 REST OF THE WORLD INFECTIOUS DISEASE MARKET, BY COUNTRY
7.6. CARDIOVASCULAR DISEASE
7.6.1 CARDIOVASCULAR DISEASE MARKET, BY REGION
7.6.1.1 NORTH AMERICA CARDIOVASCULAR DISEASE MARKET, BY COUNTRY
7.6.1.2 EUROPE CARDIOVASCULAR DISEASE MARKET, BY COUNTRY
7.6.1.3 ASIA-PACIFIC CARDIOVASCULAR DISEASE MARKET, BY COUNTRY
7.6.1.4 REST OF THE WORLD CARDIOVASCULAR DISEASE MARKET, BY COUNTRY
7.7. NEUROLOGICAL DISEASE
7.7.1 NEUROLOGICAL DISEASE MARKET, BY REGION
7.7.1.1 NORTH AMERICA NEUROLOGICAL DISEASE MARKET, BY COUNTRY
7.7.1.2 EUROPE NEUROLOGICAL DISEASE MARKET, BY COUNTRY
7.7.1.3 ASIA-PACIFIC NEUROLOGICAL DISEASE MARKET, BY COUNTRY
7.7.1.4 REST OF THE WORLD NEUROLOGICAL DISEASE MARKET, BY COUNTRY
7.8. IMMUNOLOGY
7.8.1 IMMUNOLOGY MARKET, BY REGION
7.8.1.1 NORTH AMERICA IMMUNOLOGY MARKET, BY COUNTRY
7.8.1.2 EUROPE IMMUNOLOGY MARKET, BY COUNTRY
7.8.1.3 ASIA-PACIFIC IMMUNOLOGY MARKET, BY COUNTRY
7.8.1.4 REST OF THE WORLD IMMUNOLOGY MARKET, BY COUNTRY
7.9. OTHER DISEASES
7.9.1 OTHER DISEASES MARKET, BY REGION
7.9.1.1 NORTH AMERICA OTHER DISEASES MARKET, BY COUNTRY
7.9.1.2 EUROPE OTHER DISEASES MARKET, BY COUNTRY
7.9.1.3 ASIA-PACIFIC OTHER DISEASES MARKET, BY COUNTRY
7.9.1.4 REST OF THE WORLD OTHER DISEASES MARKET, BY COUNTRY
8. GLOBAL BIOPHARMACEUTICALS MARKET, BY REGION
8.1. OVERVIEW
8.2. NORTH AMERICA
8.2.1 NORTH AMERICA BIOPHARMACEUTICALS MARKET, BY PRODUCT
8.2.2 NORTH AMERICA BIOPHARMACEUTICALS MARKET, BY APPLICATION
8.2.3 NORTH AMERICA BIOPHARMACEUTICALS MARKET, BY COUNTRY
8.2.3.1 U.S.
8.2.3.1.1 U.S. BIOPHARMACEUTICALS MARKET, BY PRODUCT
8.2.3.1.2 U.S. BIOPHARMACEUTICALS MARKET, BY APPLICATION
8.2.3.2 CANADA
8.2.3.2.1 CANADA BIOPHARMACEUTICALS MARKET, BY PRODUCT
8.2.3.2.2 CANADA BIOPHARMACEUTICALS MARKET, BY APPLICATION
8.2.3.3 MEXICO
8.2.3.3.1 MEXICO BIOPHARMACEUTICALS MARKET, BY PRODUCT
8.2.3.3.2 MEXICO BIOPHARMACEUTICALS MARKET, BY APPLICATION
8.3. EUROPE
8.3.1 EUROPE BIOPHARMACEUTICALS MARKET, BY PRODUCT
8.3.2 EUROPE BIOPHARMACEUTICALS MARKET, BY APPLICATION
8.3.3 EUROPE BIOPHARMACEUTICALS MARKET, BY COUNTRY
8.3.3.1 UK
8.3.3.1.1 UK BIOPHARMACEUTICALS MARKET, BY PRODUCT
8.3.3.1.2 UK BIOPHARMACEUTICALS MARKET, BY APPLICATION
8.3.3.2 GERMANY
8.3.3.2.1 GERMANY BIOPHARMACEUTICALS MARKET, BY PRODUCT
8.3.3.2.2 GERMANY BIOPHARMACEUTICALS MARKET, BY APPLICATION
8.3.3.3 FRANCE
8.3.3.3.1 FRANCE BIOPHARMACEUTICALS MARKET, BY PRODUCT
8.3.3.3.2 FRANCE BIOPHARMACEUTICALS MARKET, BY APPLICATION
8.3.3.4 SPAIN
8.3.3.4.1 SPAIN BIOPHARMACEUTICALS MARKET, BY PRODUCT
8.3.3.4.2 SPAIN BIOPHARMACEUTICALS MARKET, BY APPLICATION
8.3.3.5 ITALY
8.3.3.5.1 ITALY BIOPHARMACEUTICALS MARKET, BY PRODUCT
8.3.3.5.2 ITALY BIOPHARMACEUTICALS MARKET, BY APPLICATION
8.3.3.6 NETHERLANDS
8.3.3.6.1 NETHERLANDS BIOPHARMACEUTICALS MARKET, BY PRODUCT
8.3.3.6.2 NETHERLANDS BIOPHARMACEUTICALS MARKET, BY APPLICATION
8.3.3.7 REST OF EUROPE
8.3.3.7.1 REST OF EUROPE BIOPHARMACEUTICALS MARKET, BY PRODUCT
8.3.3.7.2 REST OF EUROPE BIOPHARMACEUTICALS MARKET, BY APPLICATION
8.4. ASIA-PACIFIC
8.4.1 ASIA-PACIFIC BIOPHARMACEUTICALS MARKET, BY PRODUCT
8.4.2 ASIA-PACIFIC BIOPHARMACEUTICALS MARKET, BY APPLICATION
8.4.3 ASIA-PACIFIC BIOPHARMACEUTICALS MARKET, BY COUNTRY
8.4.3.1 CHINA
8.4.3.1.1 CHINA BIOPHARMACEUTICALS MARKET, BY PRODUCT
8.4.3.1.2 CHINA BIOPHARMACEUTICALS MARKET, BY APPLICATION
8.4.3.2 JAPAN
8.4.3.2.1 JAPAN BIOPHARMACEUTICALS MARKET, BY PRODUCT
8.4.3.2.2 JAPAN BIOPHARMACEUTICALS MARKET, BY APPLICATION
8.4.3.3 INDIA
8.4.3.3.1 INDIA BIOPHARMACEUTICALS MARKET, BY PRODUCT
8.4.3.3.2 INDIA BIOPHARMACEUTICALS MARKET, BY APPLICATION
8.4.3.4 AUSTRALIA
8.4.3.4.1 AUSTRALIA BIOPHARMACEUTICALS MARKET, BY PRODUCT
8.4.3.4.2 AUSTRALIA BIOPHARMACEUTICALS MARKET, BY APPLICATION
8.4.3.5 SOUTH KOREA
8.4.3.5.1 SOUTH KOREA BIOPHARMACEUTICALS MARKET, BY PRODUCT
8.4.3.5.2 SOUTH KOREA BIOPHARMACEUTICALS MARKET, BY APPLICATION
8.4.3.6 SINGAPORE
8.4.3.6.1 SINGAPORE BIOPHARMACEUTICALS MARKET, BY PRODUCT
8.4.3.6.2 SINGAPORE BIOPHARMACEUTICALS MARKET, BY APPLICATION
8.4.3.7 INDONESIA
8.4.3.7.1 INDONESIA BIOPHARMACEUTICALS MARKET, BY PRODUCT
8.4.3.7.2 INDONESIA BIOPHARMACEUTICALS MARKET, BY APPLICATION
8.4.3.8 REST OF ASIA-PACIFIC
8.4.3.8.1 REST OF ASIA-PACIFIC BIOPHARMACEUTICALS MARKET, BY PRODUCT
8.4.3.8.2 REST OF ASIA-PACIFIC BIOPHARMACEUTICALS MARKET, BY APPLICATION
8.5. REST OF THE WORLD
8.5.1 REST OF THE WORLD BIOPHARMACEUTICALS MARKET, BY PRODUCT
8.5.2 REST OF THE WORLD BIOPHARMACEUTICALS MARKET, BY APPLICATION
8.5.3 REST OF THE WORLD BIOPHARMACEUTICALS MARKET, BY COUNTRY
8.5.3.1 LATIN AMERICA
8.5.3.1.1 LATIN AMERICA BIOPHARMACEUTICALS MARKET, BY PRODUCT
8.5.3.1.2 LATIN AMERICA BIOPHARMACEUTICALS MARKET, BY APPLICATION
8.5.3.2 MIDDLE EAST
8.5.3.2.1 MIDDLE EAST BIOPHARMACEUTICALS MARKET, BY PRODUCT
8.5.3.2.2 MIDDLE EAST BIOPHARMACEUTICALS MARKET, BY APPLICATION
8.5.3.3 AFRICA
8.5.3.3.1 AFRICA BIOPHARMACEUTICALS MARKET, BY PRODUCT
8.5.3.3.2 AFRICA BIOPHARMACEUTICALS MARKET, BY APPLICATION
9. COMPANY PROFILES
9.1. ABBOTT LABORATORIES
9.1.1 COMPANY OVERVIEW
9.1.2 COMPANY SNAPSHOT
9.1.3 OPERATING BUSINESS SEGMENTS
9.1.4 PRODUCT PORTFOLIO
9.1.5 BUSINESS PERFORMANCE
9.1.6 SALES BY BUSINESS SEGMENT
9.1.7 SALES BY GEOGRAPHIC SEGMENT
9.1.8 KEY STRATEGIC MOVES & DEVELOPMENTS
9.1.9 PRIMARY MARKET COMPETITORS
9.2. AMGEN INC
9.2.1 COMPANY OVERVIEW
9.2.2 COMPANY SNAPSHOT
9.2.3 PRODUCT PORTFOLIO
9.2.4 BUSINESS PERFORMANCE
9.2.5 SALES BY GEOGRAPHIC SEGMENT
9.2.6 KEY STRATEGIC MOVES & DEVELOPMENTS
9.2.7 PRIMARY MARKET COMPETITORS
9.3. BIOGEN
9.3.1 COMPANY OVERVIEW
9.3.2 COMPANY SNAPSHOT
9.3.3 PRODUCT PORTFOLIO
9.3.4 BUSINESS PERFORMANCE
9.3.5 SALES BY GEOGRAPHIC SEGMENT
9.3.6 KEY STRATEGIC MOVES & DEVELOPMENTS
9.3.7 PRIMARY MARKET COMPETITORS
9.4. LILLY
9.4.1 COMPANY OVERVIEW
9.4.2 COMPANY SNAPSHOT
9.4.3 PRODUCT PORTFOLIO
9.4.4 BUSINESS PERFORMANCE
9.4.5 SALES BY GEOGRAPHIC SEGMENT
9.4.6 KEY STRATEGIC MOVES & DEVELOPMENTS
9.4.7 PRIMARY MARKET COMPETITORS
9.5. F. HOFFMANN-LA ROCHE LTD
9.5.1 COMPANY OVERVIEW
9.5.2 COMPANY SNAPSHOT
9.5.3 OPERATING BUSINESS SEGMENTS
9.5.4 PRODUCT PORTFOLIO
9.5.5 BUSINESS PERFORMANCE
9.5.6 SALES BY BUSINESS SEGMENT
9.5.7 SALES BY GEOGRAPHIC SEGMENT
9.5.8 KEY STRATEGIC MOVES & DEVELOPMENTS
9.5.9 PRIMARY MARKET COMPETITORS
9.6. JOHNSON & JOHNSON SERVICES, INC.
9.6.1 COMPANY OVERVIEW
9.6.2 COMPANY SNAPSHOT
9.6.3 OPERATING BUSINESS SEGMENTS
9.6.4 PRODUCT PORTFOLIO
9.6.5 BUSINESS PERFORMANCE
9.6.6 SALES BY BUSINESS SEGMENT
9.6.7 SALES BY GEOGRAPHIC SEGMENT
9.6.8 KEY STRATEGIC MOVES & DEVELOPMENTS
9.6.9 PRIMARY MARKET COMPETITORS
9.7. MERCK & CO., INC
9.7.1 COMPANY OVERVIEW
9.7.2 COMPANY SNAPSHOT
9.7.3 OPERATING BUSINESS SEGMENTS
9.7.4 PRODUCT PORTFOLIO
9.7.5 BUSINESS PERFORMANCE
9.7.6 SALES BY BUSINESS SEGMENT
9.7.7 SALES BY GEOGRAPHIC SEGMENT
9.7.8 KEY STRATEGIC MOVES & DEVELOPMENTS
9.7.9 PRIMARY MARKET COMPETITORS
9.8. NOVO NORDISK A/S
9.8.1 COMPANY OVERVIEW
9.8.2 COMPANY SNAPSHOT
9.8.3 OPERATING BUSINESS SEGMENTS
9.8.4 PRODUCT PORTFOLIO
9.8.5 BUSINESS PERFORMANCE
9.8.6 SALES BY BUSINESS SEGMENT
9.8.7 SALES BY GEOGRAPHIC SEGMENT
9.8.8 KEY STRATEGIC MOVES & DEVELOPMENTS
9.8.9 PRIMARY MARKET COMPETITORS
9.9. PFIZER INC
9.9.1 COMPANY OVERVIEW
9.9.2 COMPANY SNAPSHOT
9.9.3 PRODUCT PORTFOLIO
9.9.4 BUSINESS PERFORMANCE
9.9.5 SALES BY GEOGRAPHIC SEGMENT
9.9.6 KEY STRATEGIC MOVES & DEVELOPMENTS
9.9.7 PRIMARY MARKET COMPETITORS
9.10. SANOFI
9.10.1 COMPANY OVERVIEW
9.10.2 COMPANY SNAPSHOT
9.10.3 OPERATING BUSINESS SEGMENTS
9.10.4 PRODUCT PORTFOLIO
9.10.5 BUSINESS PERFORMANCE
9.10.6 SALES BY BUSINESS SEGMENT
9.10.7 SALES BY GEOGRAPHIC SEGMENT
9.10.8 KEY STRATEGIC MOVES & DEVELOPMENTS
9.10.9 PRIMARY MARKET COMPETITORS
9.11. ASTRAZENECA
9.11.1 COMPANY OVERVIEW
9.11.2 COMPANY SNAPSHOT
9.11.3 PRODUCT PORTFOLIO
9.11.4 BUSINESS PERFORMANCE
9.11.5 SALES BY GEOGRAPHIC SEGMENT
9.11.6 KEY STRATEGIC MOVES & DEVELOPMENTS
9.11.7 PRIMARY MARKET COMPETITORS
9.12. MODERNA, INC.
9.12.1 COMPANY OVERVIEW
9.12.2 COMPANY SNAPSHOT
9.12.3 PRODUCT PORTFOLIO
9.12.4 BUSINESS PERFORMANCE
9.12.5 PRIMARY MARKET COMPETITORS
LIST OF TABLES
TABLE 1. GLOBAL BIOPHARMACEUTICALS MARKET VALUE, BY PRODUCT, 2020-2025, MILLION USD
TABLE 2. GLOBAL BIOPHARMACEUTICALS MARKET VALUE, BY PRODUCT, 2026-2030, MILLION USD
TABLE 3. MONOCLONAL ANTIBODY MARKET VALUE, BY REGION, 2020-2025, MILLION USD
TABLE 4. MONOCLONAL ANTIBODY MARKET VALUE, BY REGION, 2026-2030, MILLION USD
TABLE 5. NORTH AMERICA MONOCLONAL ANTIBODY MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 6. NORTH AMERICA MONOCLONAL ANTIBODY MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 7. EUROPE MONOCLONAL ANTIBODY MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 8. EUROPE MONOCLONAL ANTIBODY MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 9. ASIA-PACIFIC MONOCLONAL ANTIBODY MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 10. ASIA-PACIFIC MONOCLONAL ANTIBODY MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 11. REST OF THE WORLD MONOCLONAL ANTIBODY MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 12. REST OF THE WORLD MONOCLONAL ANTIBODY MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 13. INTERFERON MARKET VALUE, BY REGION, 2020-2025, MILLION USD
TABLE 14. INTERFERON MARKET VALUE, BY REGION, 2026-2030, MILLION USD
TABLE 15. NORTH AMERICA INTERFERON MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 16. NORTH AMERICA INTERFERON MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 17. EUROPE INTERFERON MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 18. EUROPE INTERFERON MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 19. ASIA-PACIFIC INTERFERON MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 20. ASIA-PACIFIC INTERFERON MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 21. REST OF THE WORLD INTERFERON MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 22. REST OF THE WORLD INTERFERON MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 23. INSULIN MARKET VALUE, BY REGION, 2020-2025, MILLION USD
TABLE 24. INSULIN MARKET VALUE, BY REGION, 2026-2030, MILLION USD
TABLE 25. NORTH AMERICA INSULIN MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 26. NORTH AMERICA INSULIN MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 27. EUROPE INSULIN MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 28. EUROPE INSULIN MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 29. ASIA-PACIFIC INSULIN MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 30. ASIA-PACIFIC INSULIN MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 31. REST OF THE WORLD INSULIN MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 32. REST OF THE WORLD INSULIN MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 33. GROWTH AND COAGULATION FACTOR MARKET VALUE, BY REGION, 2020-2025, MILLION USD
TABLE 34. GROWTH AND COAGULATION FACTOR MARKET VALUE, BY REGION, 2026-2030, MILLION USD
TABLE 35. NORTH AMERICA GROWTH AND COAGULATION FACTOR MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 36. NORTH AMERICA GROWTH AND COAGULATION FACTOR MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 37. EUROPE GROWTH AND COAGULATION FACTOR MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 38. EUROPE GROWTH AND COAGULATION FACTOR MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 39. ASIA-PACIFIC GROWTH AND COAGULATION FACTOR MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 40. ASIA-PACIFIC GROWTH AND COAGULATION FACTOR MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 41. REST OF THE WORLD GROWTH AND COAGULATION FACTOR MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 42. REST OF THE WORLD GROWTH AND COAGULATION FACTOR MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 43. ERYTHROPOIETIN MARKET VALUE, BY REGION, 2020-2025, MILLION USD
TABLE 44. ERYTHROPOIETIN MARKET VALUE, BY REGION, 2026-2030, MILLION USD
TABLE 45. NORTH AMERICA ERYTHROPOIETIN MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 46. NORTH AMERICA ERYTHROPOIETIN MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 47. EUROPE ERYTHROPOIETIN MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 48. EUROPE ERYTHROPOIETIN MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 49. ASIA-PACIFIC ERYTHROPOIETIN MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 50. ASIA-PACIFIC ERYTHROPOIETIN MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 51. REST OF THE WORLD ERYTHROPOIETIN MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 52. REST OF THE WORLD ERYTHROPOIETIN MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 53. VACCINE MARKET VALUE, BY REGION, 2020-2025, MILLION USD
TABLE 54. VACCINE MARKET VALUE, BY REGION, 2026-2030, MILLION USD
TABLE 55. NORTH AMERICA VACCINE MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 56. NORTH AMERICA VACCINE MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 57. EUROPE VACCINE MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 58. EUROPE VACCINE MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 59. ASIA-PACIFIC VACCINE MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 60. ASIA-PACIFIC VACCINE MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 61. REST OF THE WORLD VACCINE MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 62. REST OF THE WORLD VACCINE MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 63. HORMONE MARKET VALUE, BY REGION, 2020-2025, MILLION USD
TABLE 64. HORMONE MARKET VALUE, BY REGION, 2026-2030, MILLION USD
TABLE 65. NORTH AMERICA HORMONE MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 66. NORTH AMERICA HORMONE MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 67. EUROPE HORMONE MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 68. EUROPE HORMONE MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 69. ASIA-PACIFIC HORMONE MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 70. ASIA-PACIFIC HORMONE MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 71. REST OF THE WORLD HORMONE MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 72. REST OF THE WORLD HORMONE MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 73. OTHERS MARKET VALUE, BY REGION, 2020-2025, MILLION USD
TABLE 74. OTHERS MARKET VALUE, BY REGION, 2026-2030, MILLION USD
TABLE 75. NORTH AMERICA OTHERS MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 76. NORTH AMERICA OTHERS MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 77. EUROPE OTHERS MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 78. EUROPE OTHERS MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 79. ASIA-PACIFIC OTHERS MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 80. ASIA-PACIFIC OTHERS MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 81. REST OF THE WORLD OTHERS MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 82. REST OF THE WORLD OTHERS MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 83. GLOBAL BIOPHARMACEUTICALS MARKET VALUE, BY APPLICATION, 2020-2025, MILLION USD
TABLE 84. GLOBAL BIOPHARMACEUTICALS MARKET VALUE, BY APPLICATION, 2026-2030, MILLION USD
TABLE 85. ONCOLOGY MARKET VALUE, BY REGION, 2020-2025, MILLION USD
TABLE 86. ONCOLOGY MARKET VALUE, BY REGION, 2026-2030, MILLION USD
TABLE 87. NORTH AMERICA ONCOLOGY MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 88. NORTH AMERICA ONCOLOGY MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 89. EUROPE ONCOLOGY MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 90. EUROPE ONCOLOGY MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 91. ASIA-PACIFIC ONCOLOGY MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 92. ASIA-PACIFIC ONCOLOGY MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 93. REST OF THE WORLD ONCOLOGY MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 94. REST OF THE WORLD ONCOLOGY MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 95. BLOOD DISORDER MARKET VALUE, BY REGION, 2020-2025, MILLION USD
TABLE 96. BLOOD DISORDER MARKET VALUE, BY REGION, 2026-2030, MILLION USD
TABLE 97. NORTH AMERICA BLOOD DISORDER MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 98. NORTH AMERICA BLOOD DISORDER MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 99. EUROPE BLOOD DISORDER MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 100. EUROPE BLOOD DISORDER MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 101. ASIA-PACIFIC BLOOD DISORDER MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 102. ASIA-PACIFIC BLOOD DISORDER MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 103. REST OF THE WORLD BLOOD DISORDER MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 104. REST OF THE WORLD BLOOD DISORDER MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 105. METABOLIC DISEASE MARKET VALUE, BY REGION, 2020-2025, MILLION USD
TABLE 106. METABOLIC DISEASE MARKET VALUE, BY REGION, 2026-2030, MILLION USD
TABLE 107. NORTH AMERICA METABOLIC DISEASE MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 108. NORTH AMERICA METABOLIC DISEASE MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 109. EUROPE METABOLIC DISEASE MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 110. EUROPE METABOLIC DISEASE MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 111. ASIA-PACIFIC METABOLIC DISEASE MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 112. ASIA-PACIFIC METABOLIC DISEASE MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 113. REST OF THE WORLD METABOLIC DISEASE MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 114. REST OF THE WORLD METABOLIC DISEASE MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 115. INFECTIOUS DISEASE MARKET VALUE, BY REGION, 2020-2025, MILLION USD
TABLE 116. INFECTIOUS DISEASE MARKET VALUE, BY REGION, 2026-2030, MILLION USD
TABLE 117. NORTH AMERICA INFECTIOUS DISEASE MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 118. NORTH AMERICA INFECTIOUS DISEASE MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 119. EUROPE INFECTIOUS DISEASE MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 120. EUROPE INFECTIOUS DISEASE MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 121. ASIA-PACIFIC INFECTIOUS DISEASE MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 122. ASIA-PACIFIC INFECTIOUS DISEASE MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 123. REST OF THE WORLD INFECTIOUS DISEASE MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 124. REST OF THE WORLD INFECTIOUS DISEASE MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 125. CARDIOVASCULAR DISEASE MARKET VALUE, BY REGION, 2020-2025, MILLION USD
TABLE 126. CARDIOVASCULAR DISEASE MARKET VALUE, BY REGION, 2026-2030, MILLION USD
TABLE 127. NORTH AMERICA CARDIOVASCULAR DISEASE MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 128. NORTH AMERICA CARDIOVASCULAR DISEASE MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 129. EUROPE CARDIOVASCULAR DISEASE MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 130. EUROPE CARDIOVASCULAR DISEASE MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 131. ASIA-PACIFIC CARDIOVASCULAR DISEASE MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 132. ASIA-PACIFIC CARDIOVASCULAR DISEASE MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 133. REST OF THE WORLD CARDIOVASCULAR DISEASE MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 134. REST OF THE WORLD CARDIOVASCULAR DISEASE MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 135. NEUROLOGICAL DISEASE MARKET VALUE, BY REGION, 2020-2025, MILLION USD
TABLE 136. NEUROLOGICAL DISEASE MARKET VALUE, BY REGION, 2026-2030, MILLION USD
TABLE 137. NORTH AMERICA NEUROLOGICAL DISEASE MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 138. NORTH AMERICA NEUROLOGICAL DISEASE MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 139. EUROPE NEUROLOGICAL DISEASE MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 140. EUROPE NEUROLOGICAL DISEASE MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 141. ASIA-PACIFIC NEUROLOGICAL DISEASE MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 142. ASIA-PACIFIC NEUROLOGICAL DISEASE MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 143. REST OF THE WORLD NEUROLOGICAL DISEASE MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 144. REST OF THE WORLD NEUROLOGICAL DISEASE MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 145. IMMUNOLOGY MARKET VALUE, BY REGION, 2020-2025, MILLION USD
TABLE 146. IMMUNOLOGY MARKET VALUE, BY REGION, 2026-2030, MILLION USD
TABLE 147. NORTH AMERICA IMMUNOLOGY MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 148. NORTH AMERICA IMMUNOLOGY MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 149. EUROPE IMMUNOLOGY MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 150. EUROPE IMMUNOLOGY MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 151. ASIA-PACIFIC IMMUNOLOGY MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 152. ASIA-PACIFIC IMMUNOLOGY MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 153. REST OF THE WORLD IMMUNOLOGY MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 154. REST OF THE WORLD IMMUNOLOGY MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 155. OTHER DISEASES MARKET VALUE, BY REGION, 2020-2025, MILLION USD
TABLE 156. OTHER DISEASES MARKET VALUE, BY REGION, 2026-2030, MILLION USD
TABLE 157. NORTH AMERICA OTHER DISEASES MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 158. NORTH AMERICA OTHER DISEASES MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 159. EUROPE OTHER DISEASES MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 160. EUROPE OTHER DISEASES MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 161. ASIA-PACIFIC OTHER DISEASES MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 162. ASIA-PACIFIC OTHER DISEASES MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 163. REST OF THE WORLD OTHER DISEASES MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 164. REST OF THE WORLD OTHER DISEASES MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 165. GLOBAL BIOPHARMACEUTICALS MARKET VALUE, BY REGION, 2020-2025, MILLION USD
TABLE 166. GLOBAL BIOPHARMACEUTICALS MARKET VALUE, BY REGION, 2026-2030, MILLION USD
TABLE 167. NORTH AMERICA BIOPHARMACEUTICALS MARKET VALUE, BY PRODUCT, 2020-2025, MILLION USD
TABLE 168. NORTH AMERICA BIOPHARMACEUTICALS MARKET VALUE, BY PRODUCT, 2026-2030, MILLION USD
TABLE 169. NORTH AMERICA BIOPHARMACEUTICALS MARKET VALUE, BY APPLICATION, 2020-2025, MILLION USD
TABLE 170. NORTH AMERICA BIOPHARMACEUTICALS MARKET VALUE, BY APPLICATION, 2026-2030, MILLION USD
TABLE 171. NORTH AMERICA BIOPHARMACEUTICALS MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 172. NORTH AMERICA BIOPHARMACEUTICALS MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 173. U.S. BIOPHARMACEUTICALS MARKET VALUE, BY PRODUCT, 2020-2025, MILLION USD
TABLE 174. U.S. BIOPHARMACEUTICALS MARKET VALUE, BY PRODUCT, 2026-2030, MILLION USD
TABLE 175. U.S. BIOPHARMACEUTICALS MARKET VALUE, BY APPLICATION, 2020-2025, MILLION USD
TABLE 176. U.S. BIOPHARMACEUTICALS MARKET VALUE, BY APPLICATION, 2026-2030, MILLION USD
TABLE 177. CANADA BIOPHARMACEUTICALS MARKET VALUE, BY PRODUCT, 2020-2025, MILLION USD
TABLE 178. CANADA BIOPHARMACEUTICALS MARKET VALUE, BY PRODUCT, 2026-2030, MILLION USD
TABLE 179. CANADA BIOPHARMACEUTICALS MARKET VALUE, BY APPLICATION, 2020-2025, MILLION USD
TABLE 180. CANADA BIOPHARMACEUTICALS MARKET VALUE, BY APPLICATION, 2026-2030, MILLION USD
TABLE 181. MEXICO BIOPHARMACEUTICALS MARKET VALUE, BY PRODUCT, 2020-2025, MILLION USD
TABLE 182. MEXICO BIOPHARMACEUTICALS MARKET VALUE, BY PRODUCT, 2026-2030, MILLION USD
TABLE 183. MEXICO BIOPHARMACEUTICALS MARKET VALUE, BY APPLICATION, 2020-2025, MILLION USD
TABLE 184. MEXICO BIOPHARMACEUTICALS MARKET VALUE, BY APPLICATION, 2026-2030, MILLION USD
TABLE 185. EUROPE BIOPHARMACEUTICALS MARKET VALUE, BY PRODUCT, 2020-2025, MILLION USD
TABLE 186. EUROPE BIOPHARMACEUTICALS MARKET VALUE, BY PRODUCT, 2026-2030, MILLION USD
TABLE 187. EUROPE BIOPHARMACEUTICALS MARKET VALUE, BY APPLICATION, 2020-2025, MILLION USD
TABLE 188. EUROPE BIOPHARMACEUTICALS MARKET VALUE, BY APPLICATION, 2026-2030, MILLION USD
TABLE 189. EUROPE BIOPHARMACEUTICALS MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 190. EUROPE BIOPHARMACEUTICALS MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 191. UK BIOPHARMACEUTICALS MARKET VALUE, BY PRODUCT, 2020-2025, MILLION USD
TABLE 192. UK BIOPHARMACEUTICALS MARKET VALUE, BY PRODUCT, 2026-2030, MILLION USD
TABLE 193. UK BIOPHARMACEUTICALS MARKET VALUE, BY APPLICATION, 2020-2025, MILLION USD
TABLE 194. UK BIOPHARMACEUTICALS MARKET VALUE, BY APPLICATION, 2026-2030, MILLION USD
TABLE 195. GERMANY BIOPHARMACEUTICALS MARKET VALUE, BY PRODUCT, 2020-2025, MILLION USD
TABLE 196. GERMANY BIOPHARMACEUTICALS MARKET VALUE, BY PRODUCT, 2026-2030, MILLION USD
TABLE 197. GERMANY BIOPHARMACEUTICALS MARKET VALUE, BY APPLICATION, 2020-2025, MILLION USD
TABLE 198. GERMANY BIOPHARMACEUTICALS MARKET VALUE, BY APPLICATION, 2026-2030, MILLION USD
TABLE 199. FRANCE BIOPHARMACEUTICALS MARKET VALUE, BY PRODUCT, 2020-2025, MILLION USD
TABLE 200. FRANCE BIOPHARMACEUTICALS MARKET VALUE, BY PRODUCT, 2026-2030, MILLION USD
TABLE 201. FRANCE BIOPHARMACEUTICALS MARKET VALUE, BY APPLICATION, 2020-2025, MILLION USD
TABLE 202. FRANCE BIOPHARMACEUTICALS MARKET VALUE, BY APPLICATION, 2026-2030, MILLION USD
TABLE 203. SPAIN BIOPHARMACEUTICALS MARKET VALUE, BY PRODUCT, 2020-2025, MILLION USD
TABLE 204. SPAIN BIOPHARMACEUTICALS MARKET VALUE, BY PRODUCT, 2026-2030, MILLION USD
TABLE 205. SPAIN BIOPHARMACEUTICALS MARKET VALUE, BY APPLICATION, 2020-2025, MILLION USD
TABLE 206. SPAIN BIOPHARMACEUTICALS MARKET VALUE, BY APPLICATION, 2026-2030, MILLION USD
TABLE 207. ITALY BIOPHARMACEUTICALS MARKET VALUE, BY PRODUCT, 2020-2025, MILLION USD
TABLE 208. ITALY BIOPHARMACEUTICALS MARKET VALUE, BY PRODUCT, 2026-2030, MILLION USD
TABLE 209. ITALY BIOPHARMACEUTICALS MARKET VALUE, BY APPLICATION, 2020-2025, MILLION USD
TABLE 210. ITALY BIOPHARMACEUTICALS MARKET VALUE, BY APPLICATION, 2026-2030, MILLION USD
TABLE 211. NETHERLANDS BIOPHARMACEUTICALS MARKET VALUE, BY PRODUCT, 2020-2025, MILLION USD
TABLE 212. NETHERLANDS BIOPHARMACEUTICALS MARKET VALUE, BY PRODUCT, 2026-2030, MILLION USD
TABLE 213. NETHERLANDS BIOPHARMACEUTICALS MARKET VALUE, BY APPLICATION, 2020-2025, MILLION USD
TABLE 214. NETHERLANDS BIOPHARMACEUTICALS MARKET VALUE, BY APPLICATION, 2026-2030, MILLION USD
TABLE 215. REST OF EUROPE BIOPHARMACEUTICALS MARKET VALUE, BY PRODUCT, 2020-2025, MILLION USD
TABLE 216. REST OF EUROPE BIOPHARMACEUTICALS MARKET VALUE, BY PRODUCT, 2026-2030, MILLION USD
TABLE 217. REST OF EUROPE BIOPHARMACEUTICALS MARKET VALUE, BY APPLICATION, 2020-2025, MILLION USD
TABLE 218. REST OF EUROPE BIOPHARMACEUTICALS MARKET VALUE, BY APPLICATION, 2026-2030, MILLION USD
TABLE 219. ASIA-PACIFIC BIOPHARMACEUTICALS MARKET VALUE, BY PRODUCT, 2020-2025, MILLION USD
TABLE 220. ASIA-PACIFIC BIOPHARMACEUTICALS MARKET VALUE, BY PRODUCT, 2026-2030, MILLION USD
TABLE 221. ASIA-PACIFIC BIOPHARMACEUTICALS MARKET VALUE, BY APPLICATION, 2020-2025, MILLION USD
TABLE 222. ASIA-PACIFIC BIOPHARMACEUTICALS MARKET VALUE, BY APPLICATION, 2026-2030, MILLION USD
TABLE 223. ASIA-PACIFIC BIOPHARMACEUTICALS MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 224. ASIA-PACIFIC BIOPHARMACEUTICALS MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 225. CHINA BIOPHARMACEUTICALS MARKET VALUE, BY PRODUCT, 2020-2025, MILLION USD
TABLE 226. CHINA BIOPHARMACEUTICALS MARKET VALUE, BY PRODUCT, 2026-2030, MILLION USD
TABLE 227. CHINA BIOPHARMACEUTICALS MARKET VALUE, BY APPLICATION, 2020-2025, MILLION USD
TABLE 228. CHINA BIOPHARMACEUTICALS MARKET VALUE, BY APPLICATION, 2026-2030, MILLION USD
TABLE 229. JAPAN BIOPHARMACEUTICALS MARKET VALUE, BY PRODUCT, 2020-2025, MILLION USD
TABLE 230. JAPAN BIOPHARMACEUTICALS MARKET VALUE, BY PRODUCT, 2026-2030, MILLION USD
TABLE 231. JAPAN BIOPHARMACEUTICALS MARKET VALUE, BY APPLICATION, 2020-2025, MILLION USD
TABLE 232. JAPAN BIOPHARMACEUTICALS MARKET VALUE, BY APPLICATION, 2026-2030, MILLION USD
TABLE 233. INDIA BIOPHARMACEUTICALS MARKET VALUE, BY PRODUCT, 2020-2025, MILLION USD
TABLE 234. INDIA BIOPHARMACEUTICALS MARKET VALUE, BY PRODUCT, 2026-2030, MILLION USD
TABLE 235. INDIA BIOPHARMACEUTICALS MARKET VALUE, BY APPLICATION, 2020-2025, MILLION USD
TABLE 236. INDIA BIOPHARMACEUTICALS MARKET VALUE, BY APPLICATION, 2026-2030, MILLION USD
TABLE 237. AUSTRALIA BIOPHARMACEUTICALS MARKET VALUE, BY PRODUCT, 2020-2025, MILLION USD
TABLE 238. AUSTRALIA BIOPHARMACEUTICALS MARKET VALUE, BY PRODUCT, 2026-2030, MILLION USD
TABLE 239. AUSTRALIA BIOPHARMACEUTICALS MARKET VALUE, BY APPLICATION, 2020-2025, MILLION USD
TABLE 240. AUSTRALIA BIOPHARMACEUTICALS MARKET VALUE, BY APPLICATION, 2026-2030, MILLION USD
TABLE 241. SOUTH KOREA BIOPHARMACEUTICALS MARKET VALUE, BY PRODUCT, 2020-2025, MILLION USD
TABLE 242. SOUTH KOREA BIOPHARMACEUTICALS MARKET VALUE, BY PRODUCT, 2026-2030, MILLION USD
TABLE 243. SOUTH KOREA BIOPHARMACEUTICALS MARKET VALUE, BY APPLICATION, 2020-2025, MILLION USD
TABLE 244. SOUTH KOREA BIOPHARMACEUTICALS MARKET VALUE, BY APPLICATION, 2026-2030, MILLION USD
TABLE 245. SINGAPORE BIOPHARMACEUTICALS MARKET VALUE, BY PRODUCT, 2020-2025, MILLION USD
TABLE 246. SINGAPORE BIOPHARMACEUTICALS MARKET VALUE, BY PRODUCT, 2026-2030, MILLION USD
TABLE 247. SINGAPORE BIOPHARMACEUTICALS MARKET VALUE, BY APPLICATION, 2020-2025, MILLION USD
TABLE 248. SINGAPORE BIOPHARMACEUTICALS MARKET VALUE, BY APPLICATION, 2026-2030, MILLION USD
TABLE 249. INDONESIA BIOPHARMACEUTICALS MARKET VALUE, BY PRODUCT, 2020-2025, MILLION USD
TABLE 250. INDONESIA BIOPHARMACEUTICALS MARKET VALUE, BY PRODUCT, 2026-2030, MILLION USD
TABLE 251. INDONESIA BIOPHARMACEUTICALS MARKET VALUE, BY APPLICATION, 2020-2025, MILLION USD
TABLE 252. INDONESIA BIOPHARMACEUTICALS MARKET VALUE, BY APPLICATION, 2026-2030, MILLION USD
TABLE 253. REST OF ASIA-PACIFIC BIOPHARMACEUTICALS MARKET VALUE, BY PRODUCT, 2020-2025, MILLION USD
TABLE 254. REST OF ASIA-PACIFIC BIOPHARMACEUTICALS MARKET VALUE, BY PRODUCT, 2026-2030, MILLION USD
TABLE 255. REST OF ASIA-PACIFIC BIOPHARMACEUTICALS MARKET VALUE, BY APPLICATION, 2020-2025, MILLION USD
TABLE 256. REST OF ASIA-PACIFIC BIOPHARMACEUTICALS MARKET VALUE, BY APPLICATION, 2026-2030, MILLION USD
TABLE 257. REST OF THE WORLD BIOPHARMACEUTICALS MARKET VALUE, BY PRODUCT, 2020-2025, MILLION USD
TABLE 258. REST OF THE WORLD BIOPHARMACEUTICALS MARKET VALUE, BY PRODUCT, 2026-2030, MILLION USD
TABLE 259. REST OF THE WORLD BIOPHARMACEUTICALS MARKET VALUE, BY APPLICATION, 2020-2025, MILLION USD
TABLE 260. REST OF THE WORLD BIOPHARMACEUTICALS MARKET VALUE, BY APPLICATION, 2026-2030, MILLION USD
TABLE 261. REST OF THE WORLD BIOPHARMACEUTICALS MARKET VALUE, BY COUNTRY, 2020-2025, MILLION USD
TABLE 262. REST OF THE WORLD BIOPHARMACEUTICALS MARKET VALUE, BY COUNTRY, 2026-2030, MILLION USD
TABLE 263. LATIN AMERICA BIOPHARMACEUTICALS MARKET VALUE, BY PRODUCT, 2020-2025, MILLION USD
TABLE 264. LATIN AMERICA BIOPHARMACEUTICALS MARKET VALUE, BY PRODUCT, 2026-2030, MILLION USD
TABLE 265. LATIN AMERICA BIOPHARMACEUTICALS MARKET VALUE, BY APPLICATION, 2020-2025, MILLION USD
TABLE 266. LATIN AMERICA BIOPHARMACEUTICALS MARKET VALUE, BY APPLICATION, 2026-2030, MILLION USD
TABLE 267. MIDDLE EAST BIOPHARMACEUTICALS MARKET VALUE, BY PRODUCT, 2020-2025, MILLION USD
TABLE 268. MIDDLE EAST BIOPHARMACEUTICALS MARKET VALUE, BY PRODUCT, 2026-2030, MILLION USD
TABLE 269. MIDDLE EAST BIOPHARMACEUTICALS MARKET VALUE, BY APPLICATION, 2020-2025, MILLION USD
TABLE 270. MIDDLE EAST BIOPHARMACEUTICALS MARKET VALUE, BY APPLICATION, 2026-2030, MILLION USD
TABLE 271. AFRICA BIOPHARMACEUTICALS MARKET VALUE, BY PRODUCT, 2020-2025, MILLION USD
TABLE 272. AFRICA BIOPHARMACEUTICALS MARKET VALUE, BY PRODUCT, 2026-2030, MILLION USD
TABLE 273. AFRICA BIOPHARMACEUTICALS MARKET VALUE, BY APPLICATION, 2020-2025, MILLION USD
TABLE 274. AFRICA BIOPHARMACEUTICALS MARKET VALUE, BY APPLICATION, 2026-2030, MILLION USD
TABLE 275. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 276. ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 277. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 278. ABBOTT LABORATORIES: BUSINESS SEGMENT
TABLE 279. ABBOTT LABORATORIES: GEOGRAPHIC SEGMENT
TABLE 280. ABBOTT LABORATORIES: KEY STRATEGIC MOVES & DEVELOPMENTS
TABLE 281. AMGEN INC: COMPANY SNAPSHOT
TABLE 282. AMGEN INC: PRODUCT PORTFOLIO
TABLE 283. AMGEN INC: GEOGRAPHIC SEGMENT
TABLE 284. AMGEN INC: KEY STRATEGIC MOVES & DEVELOPMENTS
TABLE 285. BIOGEN: COMPANY SNAPSHOT
TABLE 286. BIOGEN: PRODUCT PORTFOLIO
TABLE 287. BIOGEN: GEOGRAPHIC SEGMENT
TABLE 288. BIOGEN: KEY STRATEGIC MOVES & DEVELOPMENTS
TABLE 289. LILLY: COMPANY SNAPSHOT
TABLE 290. LILLY: PRODUCT PORTFOLIO
TABLE 291. LILLY: GEOGRAPHIC SEGMENT
TABLE 292. LILLY: KEY STRATEGIC MOVES & DEVELOPMENTS
TABLE 293. F. HOFFMANN-LA ROCHE LTD: COMPANY SNAPSHOT
TABLE 294. F. HOFFMANN-LA ROCHE LTD: OPERATING SEGMENTS
TABLE 295. F. HOFFMANN-LA ROCHE LTD: PRODUCT PORTFOLIO
TABLE 296. F. HOFFMANN-LA ROCHE LTD: BUSINESS SEGMENT
TABLE 297. F. HOFFMANN-LA ROCHE LTD: GEOGRAPHIC SEGMENT
TABLE 298. F. HOFFMANN-LA ROCHE LTD: KEY STRATEGIC MOVES & DEVELOPMENTS
TABLE 299. JOHNSON & JOHNSON SERVICES, INC.: COMPANY SNAPSHOT
TABLE 300. JOHNSON & JOHNSON SERVICES, INC.: OPERATING SEGMENTS
TABLE 301. JOHNSON & JOHNSON SERVICES, INC.: PRODUCT PORTFOLIO
TABLE 302. JOHNSON & JOHNSON SERVICES, INC.: BUSINESS SEGMENT
TABLE 303. JOHNSON & JOHNSON SERVICES, INC.: GEOGRAPHIC SEGMENT
TABLE 304. JOHNSON & JOHNSON SERVICES, INC.: KEY STRATEGIC MOVES & DEVELOPMENTS
TABLE 305. MERCK & CO., INC: COMPANY SNAPSHOT
TABLE 306. MERCK & CO., INC: OPERATING SEGMENTS
TABLE 307. MERCK & CO., INC: PRODUCT PORTFOLIO
TABLE 308. MERCK & CO., INC: BUSINESS SEGMENT
TABLE 309. MERCK & CO., INC: GEOGRAPHIC SEGMENT
TABLE 310. MERCK & CO., INC: KEY STRATEGIC MOVES & DEVELOPMENTS
TABLE 311. NOVO NORDISK A/S: COMPANY SNAPSHOT
TABLE 312. NOVO NORDISK A/S: OPERATING SEGMENTS
TABLE 313. NOVO NORDISK A/S: PRODUCT PORTFOLIO
TABLE 314. NOVO NORDISK A/S: BUSINESS SEGMENT
TABLE 315. NOVO NORDISK A/S: GEOGRAPHIC SEGMENT
TABLE 316. NOVO NORDISK A/S: KEY STRATEGIC MOVES & DEVELOPMENTS
TABLE 317. PFIZER INC: COMPANY SNAPSHOT
TABLE 318. PFIZER INC: PRODUCT PORTFOLIO
TABLE 319. PFIZER INC: GEOGRAPHIC SEGMENT
TABLE 320. PFIZER INC: KEY STRATEGIC MOVES & DEVELOPMENTS
TABLE 321. SANOFI: COMPANY SNAPSHOT
TABLE 322. SANOFI: OPERATING SEGMENTS
TABLE 323. SANOFI: PRODUCT PORTFOLIO
TABLE 324. SANOFI: BUSINESS SEGMENT
TABLE 325. SANOFI: GEOGRAPHIC SEGMENT
TABLE 326. SANOFI: PRODUCT PORTFOLIO
TABLE 327. ASTRAZENECA: COMPANY SNAPSHOT
TABLE 328. ASTRAZENECA: PRODUCT PORTFOLIO
TABLE 329. ASTRAZENECA: GEOGRAPHIC SEGMENT
TABLE 330. ASTRAZENECA: PRODUCT PORTFOLIO
TABLE 331. MODERNA, INC.: COMPANY SNAPSHOT
TABLE 332. MODERNA, INC.: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 1. MARKET SHARE ANALYSIS OF TOP 10 BIOPHARMACEUTICAL PROVIDERS, 2020
FIGURE 2. GLOBAL BIOPHARMACEUTICALS MARKET VALUE, BY PRODUCT, 2021-2030, MILLION USD
FIGURE 3. MONOCLONAL ANTIBODY MARKET VALUE, BY REGION, 2021-2030, MILLION USD
FIGURE 4. NORTH AMERICA MONOCLONAL ANTIBODY MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 5. EUROPE MONOCLONAL ANTIBODY MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 6. ASIA-PACIFIC MONOCLONAL ANTIBODY MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 7. REST OF THE WORLD MONOCLONAL ANTIBODY MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 8. INTERFERON MARKET VALUE, BY REGION, 2021-2030, MILLION USD
FIGURE 9. NORTH AMERICA INTERFERON MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 10. EUROPE INTERFERON MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 11. ASIA-PACIFIC INTERFERON MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 12. REST OF THE WORLD INTERFERON MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 13. INSULIN MARKET VALUE, BY REGION, 2021-2030, MILLION USD
FIGURE 14. NORTH AMERICA INSULIN MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 15. EUROPE INSULIN MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 16. ASIA-PACIFIC INSULIN MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 17. REST OF THE WORLD INSULIN MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 18. GROWTH AND COAGULATION FACTOR MARKET VALUE, BY REGION, 2021-2030, MILLION USD
FIGURE 19. NORTH AMERICA GROWTH AND COAGULATION FACTOR MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 20. EUROPE GROWTH AND COAGULATION FACTOR MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 21. ASIA-PACIFIC GROWTH AND COAGULATION FACTOR MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 22. REST OF THE WORLD GROWTH AND COAGULATION FACTOR MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 23. ERYTHROPOIETIN MARKET VALUE, BY REGION, 2021-2030, MILLION USD
FIGURE 24. NORTH AMERICA ERYTHROPOIETIN MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 25. EUROPE ERYTHROPOIETIN MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 26. ASIA-PACIFIC ERYTHROPOIETIN MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 27. REST OF THE WORLD ERYTHROPOIETIN MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 28. VACCINE MARKET VALUE, BY REGION, 2021-2030, MILLION USD
FIGURE 29. NORTH AMERICA VACCINE MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 30. EUROPE VACCINE MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 31. ASIA-PACIFIC VACCINE MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 32. REST OF THE WORLD VACCINE MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 33. HORMONE MARKET VALUE, BY REGION, 2021-2030, MILLION USD
FIGURE 34. NORTH AMERICA HORMONE MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 35. EUROPE HORMONE MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 36. ASIA-PACIFIC HORMONE MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 37. REST OF THE WORLD HORMONE MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 38. OTHERS MARKET VALUE, BY REGION, 2021-2030, MILLION USD
FIGURE 39. NORTH AMERICA OTHERS MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 40. EUROPE OTHERS MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 41. ASIA-PACIFIC OTHERS MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 42. REST OF THE WORLD OTHERS MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 43. GLOBAL BIOPHARMACEUTICALS MARKET VALUE, BY APPLICATION, 2021-2030, MILLION USD
FIGURE 44. ONCOLOGY MARKET VALUE, BY REGION, 2021-2030, MILLION USD
FIGURE 45. NORTH AMERICA ONCOLOGY MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 46. EUROPE ONCOLOGY MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 47. ASIA-PACIFIC ONCOLOGY MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 48. REST OF THE WORLD ONCOLOGY MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 49. BLOOD DISORDER MARKET VALUE, BY REGION, 2021-2030, MILLION USD
FIGURE 50. NORTH AMERICA BLOOD DISORDER MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 51. EUROPE BLOOD DISORDER MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 52. ASIA-PACIFIC BLOOD DISORDER MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 53. REST OF THE WORLD BLOOD DISORDER MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 54. METABOLIC DISEASE MARKET VALUE, BY REGION, 2021-2030, MILLION USD
FIGURE 55. NORTH AMERICA METABOLIC DISEASE MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 56. EUROPE METABOLIC DISEASE MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 57. ASIA-PACIFIC METABOLIC DISEASE MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 58. REST OF THE WORLD METABOLIC DISEASE MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 59. INFECTIOUS DISEASE MARKET VALUE, BY REGION, 2021-2030, MILLION USD
FIGURE 60. NORTH AMERICA INFECTIOUS DISEASE MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 61. EUROPE INFECTIOUS DISEASE MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 62. ASIA-PACIFIC INFECTIOUS DISEASE MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 63. REST OF THE WORLD INFECTIOUS DISEASE MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 64. CARDIOVASCULAR DISEASE MARKET VALUE, BY REGION, 2021-2030, MILLION USD
FIGURE 65. NORTH AMERICA CARDIOVASCULAR DISEASE MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 66. EUROPE CARDIOVASCULAR DISEASE MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 67. ASIA-PACIFIC CARDIOVASCULAR DISEASE MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 68. REST OF THE WORLD CARDIOVASCULAR DISEASE MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 69. NEUROLOGICAL DISEASE MARKET VALUE, BY REGION, 2021-2030, MILLION USD
FIGURE 70. NORTH AMERICA NEUROLOGICAL DISEASE MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 71. EUROPE NEUROLOGICAL DISEASE MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 72. ASIA-PACIFIC NEUROLOGICAL DISEASE MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 73. REST OF THE WORLD NEUROLOGICAL DISEASE MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 74. IMMUNOLOGY MARKET VALUE, BY REGION, 2021-2030, MILLION USD
FIGURE 75. NORTH AMERICA IMMUNOLOGY MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 76. EUROPE IMMUNOLOGY MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 77. ASIA-PACIFIC IMMUNOLOGY MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 78. REST OF THE WORLD IMMUNOLOGY MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 79. OTHER DISEASES MARKET VALUE, BY REGION, 2021-2030, MILLION USD
FIGURE 80. NORTH AMERICA OTHER DISEASES MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 81. EUROPE OTHER DISEASES MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 82. ASIA-PACIFIC OTHER DISEASES MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 83. REST OF THE WORLD OTHER DISEASES MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 84. GLOBAL BIOPHARMACEUTICALS MARKET VALUE, BY REGION, 2021-2030, MILLION USD
FIGURE 85. NORTH AMERICA BIOPHARMACEUTICALS MARKET VALUE, BY PRODUCT, 2021-2030, MILLION USD
FIGURE 86. NORTH AMERICA BIOPHARMACEUTICALS MARKET VALUE, BY APPLICATION, 2021-2030, MILLION USD
FIGURE 87. NORTH AMERICA BIOPHARMACEUTICALS MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 88. U.S. BIOPHARMACEUTICALS MARKET, BY PRODUCT, 2021-2030, MILLION USD
FIGURE 89. U.S. BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030, MILLION USD
FIGURE 90. CANADA BIOPHARMACEUTICALS MARKET, BY PRODUCT, 2021-2030, MILLION USD
FIGURE 91. CANADA BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030, MILLION USD
FIGURE 92. MEXICO BIOPHARMACEUTICALS MARKET, BY PRODUCT, 2021-2030, MILLION USD
FIGURE 93. MEXICO BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030, MILLION USD
FIGURE 94. EUROPE BIOPHARMACEUTICALS MARKET VALUE, BY PRODUCT, 2021-2030, MILLION USD
FIGURE 95. EUROPE BIOPHARMACEUTICALS MARKET VALUE, BY APPLICATION, 2021-2030, MILLION USD
FIGURE 96. EUROPE BIOPHARMACEUTICALS MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 97. UK BIOPHARMACEUTICALS MARKET, BY PRODUCT, 2021-2030, MILLION USD
FIGURE 98. UK BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030, MILLION USD
FIGURE 99. GERMANY BIOPHARMACEUTICALS MARKET, BY PRODUCT, 2021-2030, MILLION USD
FIGURE 100. GERMANY BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030, MILLION USD
FIGURE 101. FRANCE BIOPHARMACEUTICALS MARKET, BY PRODUCT, 2021-2030, MILLION USD
FIGURE 102. FRANCE BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030, MILLION USD
FIGURE 103. SPAIN BIOPHARMACEUTICALS MARKET, BY PRODUCT, 2021-2030, MILLION USD
FIGURE 104. SPAIN BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030, MILLION USD
FIGURE 105. ITALY BIOPHARMACEUTICALS MARKET, BY PRODUCT, 2021-2030, MILLION USD
FIGURE 106. ITALY BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030, MILLION USD
FIGURE 107. NETHERLANDS BIOPHARMACEUTICALS MARKET, BY PRODUCT, 2021-2030, MILLION USD
FIGURE 108. NETHERLANDS BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030, MILLION USD
FIGURE 109. REST OF EUROPE BIOPHARMACEUTICALS MARKET, BY PRODUCT, 2021-2030, MILLION USD
FIGURE 110. REST OF EUROPE BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030, MILLION USD
FIGURE 111. ASIA-PACIFIC BIOPHARMACEUTICALS MARKET VALUE, BY PRODUCT, 2021-2030, MILLION USD
FIGURE 112. ASIA-PACIFIC BIOPHARMACEUTICALS MARKET VALUE, BY APPLICATION, 2021-2030, MILLION USD
FIGURE 113. ASIA-PACIFIC BIOPHARMACEUTICALS MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 114. CHINA BIOPHARMACEUTICALS MARKET, BY PRODUCT, 2021-2030, MILLION USD
FIGURE 115. CHINA BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030, MILLION USD
FIGURE 116. JAPAN BIOPHARMACEUTICALS MARKET, BY PRODUCT, 2021-2030, MILLION USD
FIGURE 117. JAPAN BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030, MILLION USD
FIGURE 118. INDIA BIOPHARMACEUTICALS MARKET, BY PRODUCT, 2021-2030, MILLION USD
FIGURE 119. INDIA BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030, MILLION USD
FIGURE 120. AUSTRALIA BIOPHARMACEUTICALS MARKET, BY PRODUCT, 2021-2030, MILLION USD
FIGURE 121. AUSTRALIA BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030, MILLION USD
FIGURE 122. SOUTH KOREA BIOPHARMACEUTICALS MARKET, BY PRODUCT, 2021-2030, MILLION USD
FIGURE 123. SOUTH KOREA BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030, MILLION USD
FIGURE 124. SINGAPORE BIOPHARMACEUTICALS MARKET, BY PRODUCT, 2021-2030, MILLION USD
FIGURE 125. SINGAPORE BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030, MILLION USD
FIGURE 126. INDONESIA BIOPHARMACEUTICALS MARKET, BY PRODUCT, 2021-2030, MILLION USD
FIGURE 127. INDONESIA BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030, MILLION USD
FIGURE 128. REST OF ASIA-PACIFIC BIOPHARMACEUTICALS MARKET, BY PRODUCT, 2021-2030, MILLION USD
FIGURE 129. REST OF ASIA-PACIFIC BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030, MILLION USD
FIGURE 130. REST OF THE WORLD BIOPHARMACEUTICALS MARKET VALUE, BY PRODUCT, 2021-2030, MILLION USD
FIGURE 131. REST OF THE WORLD BIOPHARMACEUTICALS MARKET VALUE, BY APPLICATION, 2021-2030, MILLION USD
FIGURE 132. REST OF THE WORLD BIOPHARMACEUTICALS MARKET VALUE, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 133. LATIN AMERICA BIOPHARMACEUTICALS MARKET, BY PRODUCT, 2021-2030, MILLION USD
FIGURE 134. LATIN AMERICA BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030, MILLION USD
FIGURE 135. MIDDLE EAST BIOPHARMACEUTICALS MARKET, BY PRODUCT, 2021-2030, MILLION USD
FIGURE 136. MIDDLE EAST BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030, MILLION USD
FIGURE 137. AFRICA BIOPHARMACEUTICALS MARKET, BY PRODUCT, 2021-2030, MILLION USD
FIGURE 138. AFRICA BIOPHARMACEUTICALS MARKET, BY APPLICATION, 2021-2030, MILLION USD
FIGURE 139. ABBOTT LABORATORIES: NET SALES, 2018–2020 ($MILLION)
FIGURE 140. ABBOTT LABORATORIES: PRIMARY MARKET COMPETITORS
FIGURE 141. AMGEN INC: NET SALES, 2018–2020 ($MILLION)
FIGURE 142. AMGEN INC: PRIMARY MARKET COMPETITORS
AMGEN INC PRIMARY MARKET COMPETITORS
FIGURE 143. BIOGEN: NET SALES, 2018–2020 ($MILLION)
FIGURE 144. BIOGEN: PRIMARY MARKET COMPETITORS
FIGURE 145. LILLY: NET SALES, 2018–2020 ($MILLION)
FIGURE 146. LILLY: PRIMARY MARKET COMPETITORS
FIGURE 147. F. HOFFMANN-LA ROCHE LTD: NET SALES, 2018–2020 ($MILLION)
FIGURE 148. F. HOFFMANN-LA ROCHE LTD: PRIMARY MARKET COMPETITORS
FIGURE 149. JOHNSON & JOHNSON SERVICES, INC.: NET SALES, 2018–2020 ($MILLION)
FIGURE 150. JOHNSON & JOHNSON SERVICES, INC.: PRIMARY MARKET COMPETITORS
FIGURE 151. MERCK & CO., INC: NET SALES, 2018–2020 ($MILLION)
FIGURE 152. MERCK & CO.: PRIMARY MARKET COMPETITORS
FIGURE 153. NOVO NORDISK A/S: NET SALES, 2018–2020 ($MILLION)
FIGURE 154. NOVO NORDISK A/S: PRIMARY MARKET COMPETITORS
FIGURE 155. PFIZER INC: NET SALES, 2018–2020 ($MILLION)
FIGURE 156. PFIZER INC: PRIMARY MARKET COMPETITORS
FIGURE 157. SANOFI: NET SALES, 2018–2020 ($MILLION)
FIGURE 158. SANOFI: PRIMARY MARKET COMPETITORS
FIGURE 159. ASTRAZENECA: NET SALES, 2018–2020 ($MILLION)
FIGURE 160. ASTRAZENECA: PRIMARY MARKET COMPETITORS
FIGURE 161. MODERNA, INC.: NET SALES, 2018–2020 ($MILLION)
FIGURE 162. MODERNA, INC.: PRIMARY MARKET COMPETITORS